Udager et al. first reported the presence of activating EGFR mutations in 88% of IP and 77% of IP-SCC cases, and this phenomenon might be distinct in IP and IP-malignant transformation among sinonasal squamous tumors [10]. Here, EGFR is linked to incontinentia pigmenti.